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Abstract As a member of adherens junction, p120-cate-
nin (p120ctn) plays a major role in cell adhesions through
stabilization of E-cadherin. p120ctn is transcriptionally
down-regulated in non-small cell lung cancer (NSCLC),
although the molecular mechanisms underlying p120ctn
repression are incompletely deﬁned. Here we further
investigated transcriptional regulation of p120ctn in
NSCLC. We prepared a promoter reporter plasmid con-
struct that contained p120ctn promoter region from posi-
tion -1082 to ?320 relative to transcription start site.
Through serial deletion mutation analysis of the p120ctn
promoter, we pinpointed cis-acting elements involved in
regulation of p120ctn. We identiﬁed transcription factor
SP1 as a transcriptional repressor of p120ctn that directly
binds to segment (-9t o?36) of the p120ctn promoter.
SP1 can receive multiple signals from several intracellular
signaling pathways. Through examination of SP1 binding
partners, we identiﬁed proto-oncogene c-Crk to be
involved in transcriptional down-regulation of p120ctn.
RNAi mediated silencing of CRK in A549, H157 and H358
cells increased p120ctn protein levels. On the other hand,
over-expression of CRK-I and CRK-II in NSCLC cells
down-regulated p120ctn, an effect that was abrogated by
simultaneous silencing of SP1. In summary, our data pro-
vide evidence for the role of c-Crk proto-oncogene in
transcriptional repression of p120ctn that further clariﬁes
the mechanism by which this biochemical signal promotes
metastasis in NSCLC.
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Introduction
As a member of adherens junction, the p120-catenin protein
(p120ctn) plays an important role in cell–cell adhesions.
Loss of p120ctn expression results in destabilization of the
E-cadherin complex thereby promoting tumor invasion and
metastasis [3, 5, 6, 9, 11, 23, 24, 29–31]. Down-regulation
of p120ctn has been shown to disrupt cell–cell adhesions in
several studies [6, 9, 21, 29, 30]. p120ctn knockdown by
RNA interference results in dose-dependent elimination of
epithelial, placental, neuronal and vascular endothelial
Electronic supplementary material The online version of this
article (doi:10.1007/s10585-011-9378-8) contains supplementary
material, which is available to authorized users.
F. Mortazavi (&)   S. Dubinett   M. Rettig
Department of Medicine, David Geffen School of Medicine at
UCLA, Los Angeles, CA, USA
e-mail: fredmortazavi@ucla.edu
F. Mortazavi   M. Rettig
Division of Hematology and Oncology, West Los Angeles VA,
11301 Wilshire Blvd, W111H, West Los Angeles, CA, USA
S. Dubinett
Division of Pulmonary and Critical Care Medicine, UCLA Lung
Cancer Research Program, David Geffen School of Medicine at
UCLA, Los Angeles, CA, USA
S. Dubinett
Division of Pulmonary and Critical Care Medicine, West Los
Angeles, CA, USA
S. Dubinett
Department of Pathology, David Geffen School of Medicine at
UCLA, Los Angeles, CA, USA
M. Rettig
Department of Urology, David Geffen School of Medicine at
UCLA, Los Angeles, CA, USA
123
Clin Exp Metastasis (2011) 28:391–404
DOI 10.1007/s10585-011-9378-8cadherins and complete loss of cell–cell adhesion [6].
Moreover, decreased expression of p120ctn is observed in
multiple tumors types and is associated with increased
metastatic potential of these tumors including60–80% of all
subtypes of NSCLC [5, 12–15, 24, 27, 29, 31].
Decreased expression of p120ctn in NSCLC is most
commonly due to transcriptional down-regulation of the
p120ctn gene [12, 15, 19]. We recently cloned the p120ctn
promoter into a ﬁreﬂy luciferase reporter vector and
observed that promoter activity of p120ctn is signiﬁcantly
reduced in NSCLC cell lines compared to immortalized
normal human respiratory epithelial cells [19]. Through
serial deletion analysis of the p120ctn promoter, we iden-
tiﬁed two separate regions of this promoter both of which
hold signiﬁcant transcriptional regulatory functions [i.e.,
segments (?267 to ?282) and (-9t o?36) relative to
transcription initiation site]. We recently published the
results of p120ctn promoter analysis between positions
?267 and ?282 and reported the role of FOXC2 (mesen-
chymal forkhead related protein) in transcriptional down-
regulation of the p120ctn [19]. Here, we report our analysis
results of segment (-9t o?36) of the p120ctn promoter.
We identiﬁed transcription factor SP1 as another regulator
of the p120ctn transcription which directly binds to seg-
ment (-9t o?36) of this promoter.
Speciﬁcity protein 1 (SP1) belongs to a universally
expressedzinc-ﬁngerDNAbindingproteinsthatareinvolved
in transcriptional regulation of many genes [26]. Multiple
proteinsincludingothertranscriptionfactorscaninteractwith
SP1 and thereby transduce their respective signal for gene
regulation through SP1. We examined several binding part-
ners of SP1 and recognized the role of the c-Crk proto-
oncogene in transcriptional down-regulation of the p120ctn.
Materials and methods
Cell cultures
A549,H157andH358cellswereroutinelyculturedinRPMI
supplemented with antibiotics and 10% heat-inactivated
FBS(OmegaScientiﬁc,Tarzana,CA).Immortalizednormal
human epithelial cells (BEAS-2B) were cultured in BEBM
medium supplemented with all the additives (Lonza/Clo-
netics Corporation, Switzerland; Catalog No. CC-3170).
Measurement of p120ctn promoter activity by dual
luciferase assay
p120ctn promoter constructs were transfected into NSCLC
cell lines as well as immortalized normal human respiratory
epithelialcells(BEAS-2B)byLipofectamine2000(Invitrogen).
Twenty-four hours after transfection cells were washed
with PBS and lysed using a Branson Soniﬁer in 19 passive
lysis buffer (Promega) at room temperature (RT). Reporter
gene expression was assessed by using the Dual-Luciferase
Reporter Assay System kit (Promega) according to manu-
facturer’s instructions in a TD-20/20 Luminometer (Turner
Biosystems, Sunnyvale, CA). We normalized for transient
transfection efﬁciency (i.e. ﬁreﬂy luciferase activity) by
co-transfection of a Renilla luciferase expressing control
vector (pRL-SV40). All experiments were performed in
triplicate and were reported as means ± standard deviation
(s.d.), and each experiment was performed at least twice.
siRNA mediated gene silencing
Initially, A549 cells were transfected with two independent
sets of siRNA for p120ctn, AP2, SP1, and CRK. In the case
of NF-1 we chose one set of siRNA since there was no
signiﬁcant correlation between NF-1 silencing and the
p120ctn promoter activity. Transfections were performed
by using Lipofectamine 2000 (Invitrogen).
The siRNA duplex sequences that we used to silencing
the above mentioned genes are as follows:
p120ctn #1:
50-GCUAUGAUGACCUGGAUUAdtdt-30
50-UAAUCCAGGUCAUCAUAGCdtdt-30
p120ctn #2:
50-CUAUGAUGACCUGGAUUAUdtdt-30
50-AUAAUCCAGGUCAUCAUAGdtdt-30
AP2 #1:
50-GCCAAAGCAGUAGCUGAAUdtdt-30
50-AUUCAGCUACUGCUUUGGCdtdt-30
AP2 #2:
50-GAUCAAACUGUAAUUAAGAdtdt-30
50-UCUUAAUUACAGUUUGAUCdtdt-30
SP1 #1:
50-GCAACAUGGGAAUUAUGAAdtdt-30
50-UUCAUAAUUCCCAUGUUGCdtdt-30
SP1 #2:
50-CAUACCAGGUGCAAACCAAdtdt-30
50-UUGGUUUGCACCUGGUAUGdtdt-30
NF1 #1:
50-CCAAAGACGUGGUUGAUGAdtdt-30
50-UCAUCAACCACGUCUUUGGdtdt-30
CRK #1:
50-CUGCUUACCCUGAUUUAUUdtdt-30
50-AAUAAAUCAGGGUAAGCAUdtdt-30
CRK #2:
50-CCUGAUUUAUUCAGUGGUUdtdt-30
50-AACCACUGAAUAAAUCAGGdtdt-30
As a control, scrambled non-silencing siRNA was used
(Sigma-Aldrich Cat number SIC002-10NMOL). Concen-
trations of siRNA were kept at 100 nM among groups.
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We extracted total RNA from each NSCLC cell line by
using Trizol method and prepared cDNA using Super-
Script-II RT Kit (Invitrogen) and Oligo (dT)s according to
the manufacturer’s instructions. The following primer sets
were used to amplify a short segment of cDNA for each
gene.
AP2-forward:
50-TATCTACCCCCAGTCGCAAG-30
AP2-reverse:
50-TACCCGGGTCTTCTACATGC-30
NF-1-forward:
50-GCCATTCTCAAGAGGCAGTC-30
NF-1-reverse:
50-CATTCGTATTGCTGGGTGTG-30
SP1-forward:
50-GGAGAGCAAAACCAGCAGAC-30
SP1-reverse:
50-CAATGGGTGTGAGAGTGGTG-30
MYC-forward:
50-CTCCTGGCAAAAGGTCAGAG-30
MYC-reverse:
50-GGCCTTTTCATTGTTTTCCA-30
E2F-1-forward:
50-GCCAAGAAGTCCAAGAACCA-30
E2F-1-reverse:
50-CTCAGGGCACAGGAAAACAT-30
SRC-forward:
50-CTGTTCGGAGGCTTCAACTC-30
SRC-reverse:
50-TGAGAGGCAGTAGGCACCTT-30
CRK forward:
50-GCAAGAGAGGGATGATTCCA-30
CRK reverse:
50-ATGGGAAGTGACCTCGTTTG-30
Actin-forward:
50-TGACGGGGTCACCCACACTGTGCCC
ATCTA-30
Actin-reverse:
50-CTAGAAGCATTTGCGGTGGACGATG
GA-30
All PCR reactions were performed by using Taq DNA
polymerase (Roche Applied Science) in an Eppendorf
Mastercycler thermo cycler (Eppendorf).
Measurement of mRNA level by qRT-PCR
We used TaqMan probes and SYBR Green methods for
measurement of mRNA level following gene silencing. In
case of p120ctn, mRNA level in NSCLC cell lines were
measured by TaqMan probes; assay IDs: Hs00931670_m1
and Hs00183425_m1 (Applied Biosystems, Foster City,
CA). For CRK, AP2, NF-1 and SP1 we used SYBR Green
method with the above mentioned primers.
In each cell type, total RNA was extracted by using
Trizol method and cDNA was prepared by an RT-PCR
reaction using SuperScript-II RT Kit (Invitrogen) and
Oligo (dT)s according to the manufacturer’s instructions.
For each cDNA sample an internal control (beta actin) was
also measured by TaqMan probe. In order to compare the
expression level of mRNA between samples, we used the
Comparative Ct Method (DDCt). Relative expression of
mRNA compared to beta actin in each sample was calcu-
lated (DCt) and relative expression of mRNA among
samples was determined by calculating the difference in
(DCt) between samples (DDCt). All relative quantitative
PCRs were performed, recorded, and analyzed by using the
ABI 7300Prism Sequence Detection System (Applied
Biosystems, Foster City, CA). All samples were carried out
in triplicate (10 ng of total RNA per well) and repeated at
least twice. Controls without template or reverse trans-
criptase were run in each experiment.
Western blots
NSCLC cell lines were seeded in 10 cm Petri dishes at
5 9 10
5 cells per dish, which resulted in 30–40% conﬂu-
ency 24 h after plating. Cells were harvested at 24 h by
adding trypsin, pelleted and lysed in 100 ll of lysis buffer
(NaCl 15 mM; EDTA 0.5 mM; Tris 10 mM) using a
Branson Soniﬁer. Cell debris was collected by centrifuga-
tion at 4C, and protein concentration was measured by the
BCA method. Protein was resolved by SDS-PAGE and was
transferred to a nitrocellulose membrane. The membrane
was blocked with TBS with 5% nonfat powdered milk.
Membranes were immunoblotted with the following
primary antibodies: p120ctn (BD biosciences Cat. number
610133); SP1 (Abcam Cat. number 58199); E-cadherin
(BD biosciences Cat. number 61081); CRK II (Santa Cruz
Biotechnology Cat. number sc-289); CRK I/II (Santa Cruz
Biotechnology Cat. number sc-17989). Horse radish per-
oxidase conjugated secondary antibodies were used for
detection of bands by chemiluminescence (ECL western
blotting detection reagents, Amersham Biosciences, Pis-
cataway, NJ, USA).
Chromatin immunoprecipitation assay (ChIP)
We followed the method described by Boyd and Farnham
[2] and Y. Shang et al. [25] with some modiﬁcations. 1.
A549 and H157 cells (2 9 10
7 in a 150 mm dish) were
grown at conﬂuence. 2. Cells were cross-linked by adding
formaldehyde to a ﬁnal concentration of 1% (0.68 ml of
37%/25 ml media) directly into the media and mixed on a
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ing was stopped by adding glycine to a ﬁnal concentration
of 125 mM (3.75 ml of 1 M/25 ml media) for 5 min at
room temperature. 4. The cell monolayers were washed
three times with ice-cold 19 PBS. Cells were then scraped
into 19 PBS (5 ml) plus protease inhibitors and collected
by centrifugation (7009g for 4 min). 5. Cell pellets were
re-suspended in cell lysis buffer [5 mM Pipes (KOH), pH
8.0/85 mM KCl/0.5% NP-40] containing the following
protease inhibitors 1 lg/ml leupeptin, 1 lg/ml aprotinin
and 1 mM PMSF and incubated for 10 min on ice. The
efﬁciency of cell lysis was checked with trypan blue and if
needed cells were homogenized on ice with a type B
homogenizer. 6. Nuclei were pelleted by centrifugation
(5000 rpm for 5 min) and re-suspend in nuclear lysis buffer
[50 mM Tris, pH 8.1/10 mM EDTA/1% SDS containing
the same protease inhibitors as in cell lysis buffer] followed
by incubation on ice for 10 min. 7. Chromatin was shred-
ded by using a soniﬁer to an average length of about
600 bp while keeping samples on ice. For both cell lines,
we used a Branson Soniﬁer 250 with power setting 5 in
20-s. bursts followed by 1 min of cooling on ice for a total
sonication time of 3 min per sample. 8. Debris was cleared
by centrifugation at maximum speed for 10 min at 4C. 9.
The supernatant was transferred to a new tube and dilute
5-fold in ChIP dilution buffer [0.01% SDS/1.1% Triton
X-100/1.2 mM EDTA, 16.7 mM Tris, pH 8.1/167 mM
NaCl plus protease inhibitors]. 10. To reduce nonspeciﬁc
background, we pre-cleared the samples with 80 llo f
salmon sperm DNA/protein A/G agarose slurry for 30 min
at 4C with agitation. 11. We collected the beads by a brief
centrifugation and separated the supernatant fraction. 12.
20% of the total supernatant was saved as total input
control and processed with the eluted Immunoprecipitates.
13. The rest of the supernatant was divided into two frac-
tions: one for an IP with IgG control and the second was
incubated with 5 lg of SP1 antibody (Abcam Cat. number
ab13405) overnight at 4C with rotation. 14. We collected
immune complexes with 60 ll of the salmon sperm DNA/
protein A/G agarose slurry for 1 h at 4C with rotation. 15.
Beads were then washed consecutively for 3–5 min on a
rotating platform with 1 ml of each solution:
Low salt wash buffer [0.1% SDS/1% Triton X-100/
2 mM EDTA, 20 mM Tris, pH 8.1/150 mM NaCl] b. high
salt wash buffer [0.1% SDS/1% Triton X-100, 2 mM
EDTA, 20 mM Tris, pH 8.1, 500 mM NaCl] c. LiCl wash
buffer [0.25 M LiCl/1% NP40/1% deoxycholate, 1 mM
EDTA/10 mM Tris, pH 8.0] d. twice in 19 TE buffer. 16.
Complexes were eluded by adding 250 ll of elution buffer
[1% SDS/0.1 M NaHCO3] to pelleted beads by mixing and
shaking by vortexer for at least 15 min. Beads and eluted
proteins were separated by centrifugation at 14,000 rpm for
3 min. This step was repeated and both elutants were
combined in the same tube. 17. Formaldehyde cross links
were reversed by adding 1 ll 10 mg/ml RNase and 5 M
NaCl to a ﬁnal concentration of 0.3 M to the elutants and
incubation in a 65C for 4–5 h. 18. DNA was precipitated
by adding 2 1/2 volumes of 100% ethanol overnight at
-20C. 19. DNA and debris were collected by centrifu-
gation at high speed and re-suspend in 100 ll of water. We
added 2 ll of 0.5 M EDTA, 4 ll 1 M Tris, pH 6.5 and 1 ll
of 20 mg/ml Proteinase K and incubated samples for 1–2 h
at 45C and puriﬁed DNA by using QiaQuick spin col-
umns. 20. 2 ll of this DNA samples was used in qRT-PCR
reaction by SYBR Green with the following primers.
SP1 ChIP-forward:
50-GGTTCCTATTGGAAGCTCAC-30
SP1 ChIP-reverse:
50-CTCTCTCTCTCCCTCT-30
Immunoprecipitation
We grew A549 and H157 cells in 100 cm
2 dishes to 90%
conﬂuency. Cells were washed with 2 ml PBS and scraped
off in 1 ml PBS. Cells were transferred to Eppendorf tubes
and spun at 1000 RPM at 4C for 10 min. Then we prepared
a cell lysate by re-suspending the cells in ice-cold gentle
lysis buffer [10 mM Tris–HCl pH 7.5; 10 mM NaCl; 2 mM
EDTA; 0.1% Triton-X100; 1 mM PMSF; 2 lg/ml aproti-
nin; 2 lg/ml leupeptin] (approximately 700 ll per 2 9 10
6
cells). Cells were incubated on ice for 5 min before adding
NaCl to 150 mM followed by incubating on ice for 10 min.
Next, cells were spun again at 14,000 rpm in 4C for
15 min. We split the supernatant in two fractions and
incubated them with either 4 lg of anti CRK antibody
(Santa Cruz Biotechnology Cat. number sc-289); SP1
(Abcam Cat. number 13405) or 4 lg of control IgG for 4 h.
Subsequently, we added 25 ll of protein G plus/protein A
agarose suspension (Calbiochem Cat. number IP05) and
incubated overnight at 4C with agitation. We washed the
beads 8 times with 1 ml of ice cold NET [50 mM Tris–HCl
pH 7.5; 150 mM NaCl; 0.05% Triton-X100] for 1 min each
time spinning at 1,000 rpm at 4C. Eventually, we eluted
the immunoprecipitate by adding SDS directly to beads and
proceeded with western blotting with mouse anti SP1
antibody (Abcam Cat. number ab58199).
CRK over-expression
We obtained a CRK-I expression plasmid and its corre-
sponding empty control vector from (OriGene Technolo-
gies Cat number sc109105 and PCMV6XL5) as well as
CRK-II expression plasmid (OriGene Technologies Cat
number RC201701 and PCMV6-Entry). For CRK-I, H358
cells were transiently transfected with the above mentioned
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hours after transfection, cells were washed and transfected
again with appropriate siRNA (SP1 or non-silencing
siRNA). In case of CRK-II, A549 cells were transfected
with the appropriate plasmids and 48 h post transfection,
cells were selected by G418 at 1000 lg/ml for 2 weeks.
We used 1.0 lg of plasmid DNA for every well in a 6 well
plate format. Following selection of stably transfected
cells, these cells were transfected with appropriate siRNA
(SP1 or non-silencing siRNA). Cells were kept in 37C
incubator and were analyzed by western blotting at 48 h
following siRNA transfection.
Results
Promoter activity of p120ctn is signiﬁcantly reduced
in NSCLC cell lines compared to immortalized normal
human respiratory epithelial cell line (BEAS-2B)
We recently reported that altered expression of p120ctn
was attributable to transcriptional down-regulation of the
p120ctn promoter [19]. We compared p120ctn promoter
activity in NSCLC cell lines to that of an immortalized
normal respiratory epithelial cell line, BEAS-2B. BEAS-
2B cells represent human bronchial epithelial cells infected
by the SV40 virus, which results in a non-tumorigenic
immortalized cell line. We ampliﬁed promoter region of
the p120ctn spanning from position -1082 to ?320 rela-
tive to transcriptional start site and cloned the resulted
amplicon into a ﬁreﬂy luciferase reporter vector (pGL4.16
Luciferase reporter vector, Promega) to generate
p120ctn
short-luc. Our p120ctn promoter construct was
transiently transfected into several NSCLC cell lines as
well as BEAS-2B cells and reporter gene activity was
measured at 24 h. The p120ctn promoter activity in all
tested NSCLC cells was signiﬁcantly lower than BEAS-2B
cells (Fig. 1a). This ﬁnding suggests that differential tran-
scriptional regulation of p120ctn in malignant versus non-
malignant lung epithelial cells contributes to lower
expression level of p120ctn in malignant lung epithelium.
Two distinct regions of p120ctn promoter harbor
signiﬁcant transcriptional regulatory elements
Considering the ﬁnding of reduced p120ctn promoter
activity in NSCLC cells, we next sought to identify addi-
tional regulatory elements that mediate transcriptional
repression of the p120ctn in malignant lung epithelium. In
order to identify the important and relevant sequences in
the p120ctn promoter region involved in p120ctn tran-
scriptional down-regulation, we performed serial deletions
of our p120ctn
short-luc promoter construct.
1 Speciﬁcally,
we created 30 deletion mutant constructs spanning from
position -221 to positions ?267, ?239, ?69, ?19, -9,
-20 and -71 relative to transcription initiation site. The
schematic view of the deletion mutant constructs and their
relative promoter activity compared to full length promoter
in A549 cells are shown in (Fig. 1b).
Deletion of the ﬁrst 53 nucleotides from the 30 end of
our p120ctn
short-luc promoter construct, [mutant (-221 to
?267)] resulted in a robust increase in promoter activity
compared to full length construct. Detailed analysis of this
segment of the p120ctn promoter revealed that transcrip-
tion factor FOXC2 (mesenchymal forkhead related protein)
in fact binds to segment (?267 to ?282) of the p120ctn
promoter and negatively regulates this gene [19].
Further 30 deletions of p120ctn
short-luc construct
revealed other key regulatory regions of p120ctn promoter.
Noticeably, sequential 30 deletion of segment (-9t o?36)
of the p120ctn
short-luc construct resulted in a dramatic
decrease in luciferase activity [mutants (-221 to -9);
(-221 to ?19) and (-221 to ?36)] (Fig. 1b). This signiﬁ-
cant lossof promoter activity, identiﬁessegment (-9to?36)
ofthep120ctnaspartofthecorepromoterregionofthisgene
which could contain repressive or activating cis-acting ele-
ments. Interestingly, upon deletion of segment (-9 to ?36),
mostoftheobserveddifferenceinpromoteractivitybetween
A549 and BEAS-2B cells disappeared [mutant (-221 to
-9)] (Fig. 2b). This ﬁnding suggests that the residing
cis-acting elements within this segment of the p120ctn
promoter mediate the observed difference in the p120ctn
promoter activity between BEAS-2B and A549 cells.
In order to identify putative cis-acting elements that
regulate p120ctn promoter, we used a computer based
DNA sequence analysis program known as AliBaba2, a
software program for predicting binding sites of tran-
scription factors in an unknown DNA sequence utilizing
the TRANSFAC database [8]. Analysis of the p120ctn
promoter region in the vicinity of segment (-9t o?36)
predicted binding sites for the following transcription fac-
tors: NF-1, AP2 and SP1 as well as a NFjB site, imme-
diately 50 to this segment (Fig. 1d).
Transcription factor SP1 mediates transcriptional
regulation of p120ctn
In order to identify the relevant cis-acting elements within
the segment (-9t o?36) of p120ctn promoter, we chose to
examine the corresponding transcription factor for each
predicted cis-acting element. For this purpose, we silenced
each putative transcription factor by RNA interference. We
1 For detailed methodology of our deletion mutation analysis of the
p120ctn promoter, please refer to [19].
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factors AP2, NF-1and SP1 and tested the silencing efﬁ-
ciency of each siRNA separately (Supplemental Fig. 1).
Next we examined the p120ctn promoter activity in A549
and BEAS-2B cells following silencing the above men-
tioned transcription factors. We used two separate p120ctn
promoter constructs [i.e., constructs (-221 to -9) and
(-221 to?36)] forthisanalysis. Thedifference of promoter
activity between these two constructs would be a reﬂection
of segment (-9t o?36) role in transcriptional regulation of
the p120ctn. Compared to scrambled control siRNA, SP1
silencing resulted in a robust increase in p120ctn promoter
C
A
D
B
Fig. 1 a Promoter analysis of p120ctn in A549 (NSCLC) and BEAS-
2B (immortalized normal human epithelium) cell lines. Results are
normalized for transient transfection efﬁciency (i.e. ﬁreﬂy luciferase
activity) by co-transfection of a Renilla luciferase expressing control
vector (pRL-SV40). Numbers on horizontal axis indicate quantity of
DNA transfected. Promoter activity of A549 cells are signiﬁcantly
reduced compared to BEAS-2B cells. b Analysis of p120ctn promoter
by creating serial deletion constructs. These deletion constructs of full
length p120ctn promoter were prepared by deletions from both 50 and
30 ends of the p120ctn
short-luc construct. Both A549 and BEAS-2B
cells were transfected with this mutant constructs and 24 h later cells
were lysed and subjected to dual Luciferase assay, data only shown
for A549 cells. Relative promoter activity is normalized to full length
promoter activity in A549 cells. p120ctn promoter activity signiﬁ-
cantly changes upon deletion segments (-9t o?36) and (?267 to
?320). c Chromatin immunoprecipitation (ChIP) in A549 and H157
cells; immunoprecipitation with anti-SP1 antibody or IgG control,
PCR with primers encompassing segment (-56 to ?111) of the
p120ctn promoter. Error bars represent 95% conﬁdence interval.SP1
binds to the p120ctn promoter. d Schematic view of the p120ctn core
promoter region and putative cis-acting elements both at the 50 and 30
sides of transcription initiation site that were predicted by Alibaba2
analysis. Binding sites for transcription factors NF-1, AP-2 and SP1
are predicted within segment (-9t o?36) of the p120ctn promoter
396 Clin Exp Metastasis (2011) 28:391–404
123activity in A549 cells, whereas silencing NF-1 had no effect
on promoter activity and AP2 silencing resulted in a modest
increase in p120ctn promoter activity that was substantially
less than that observed for SP1 silencing (Fig. 2).
It is noteworthy that baseline promoter activity and
expression level of p120ctn is higher in non-malignant,
immortalized BEAS-2B cells compared to NSCLC cell
lines including A549 cells [19]. Importantly, the p120ctn
promoter activity following SP1 silencing led to a reversal
of the p120ctn promoter activity pattern with greater
activity in A549 cells compared to BEAS-2B cells. In order
to test the generalizability of the SP1 role in the regulation
of p120ctn, we examined p120ctn promoter activity fol-
lowing silencing SP1 in two other NSCLC cell lines. We
also observe increasing p120ctn promoter activity and
p120ctn protein level following silencing transcription
factor SP1 in H358 and H157 cells (Fig. 3). The above
ﬁndings strongly point to the fact that transcription factor
SP1 is involved in transcriptional repression of p120ctn.
SP1 directly binds to p120ctn promoter
In order to conﬁrm the direct binding of SP1 to the segment
(-9t o?36) of the p120ctn promoter, we investigated this
DNA–proteininteractionbychromatinimmunoprecipitation
assay (ChIP). As described in the materials and methods
section, a 25 lg chromatin sample of A549 and H157
NSCLCcellswerepreparedandincubatedwithSP1antibody
or control IgG. Following immunoprecipitation and appro-
priate washing steps, harvested DNA was used in a real-time
PCR reaction to amplify a short 167 bp segment of the
p120ctn promoter from position-56 to ?111 encompassing
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123the segment (-9t o?36) (Fig. 1c). We observed that a SP1
antibody successfully immunoprecipitated fragments of the
p120ctn promoter, which contain segment (-9t o?36)
thereby conﬁrming the direct binding of SP1 to the endoge-
nous p120ctn promoter in these two NSCLC cell lines.
CRK expression level in NSCLC cells in inversely
correlated with p120ctn expression
Speciﬁcity protein 1 (SP1) belongs to a family of univer-
sally expressed zinc-ﬁnger DNA binding proteins, which
are involved in transcriptional regulation of a variety of
genes. Multiple signaling pathways transduce their signals
through interactions with SP1 including EGFR-through
ERK2, cyclin-dependent kinase-2 (CDK2), protein kinase C,
HGF- throughPI3kinaseand TGF-b -throughSMAD2/3 [4].
Moreover, several other proteins including oncoproteins,
such as c-Abl, c-Crk, c-Myc, E2F-1 and c-Src, make binary
interactions with SP1 [28]. Therefore, we reasoned that
studying protein–protein interactions that involve SP1
would provide insight into the abnormal signals that
mediate transcriptional down-regulation of p120ctn in
0
100
200
300
400
500
600
700
N
o
r
m
a
l
i
z
e
d
r
e
l
a
t
i
v
e
 
l
u
c
i
f
e
r
a
s
e
 
a
c
t
i
v
i
t
y
A549 SP1
p120ctn
Actin
H358
0
100
200
300
400
500
600
700
N
o
r
m
a
l
i
z
e
d
r
e
l
a
t
i
v
e
 
l
u
c
i
f
e
r
a
s
e
 
a
c
t
i
v
i
t
y
SP1
Actin
p120ctn
H157 SP1
Actin
p120ctn
0
50
100
150
200
250
300
350
400
N
o
r
m
a
l
i
z
e
d
 
r
e
l
a
t
i
v
e
 
l
u
c
i
f
e
r
a
s
e
 
a
c
t
i
v
i
t
y
p120ctn promoter construct (-221 to -9) p120ctn promoter construct (-221 to +36)
98 kD
50 kD
98 kD
98 kD
50 kD
98 kD
98 kD
50 kD
98 kD
SP1 siRNA Scr. siRNA
SP1 siRNA Scr. siRNA
SP1 siRNA Scr. siRNA
Fig. 3 Relative p120ctn
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398 Clin Exp Metastasis (2011) 28:391–404
123NSCLC.Forthispurposeweexaminedtheexpressionlevels
ofSP1andseveralSP1-interactingoncogenesandcorrelated
themwiththeexpressionlevelofp120ctninseveralNSCLC
celllinesaswell asBEAS-2Bcells(Fig. 4).Speciﬁcally, we
compared mRNA levels of CRK, MYC, E2F-1, SRC and
ABL in a panel of NSCLC and BEAS-2B cells by RT-PCR
(Fig. 4b). We did not observe a linear correlation between
SP1 expression level and p120ctn in our panel of cells. Two
celllineswithhigherE-cadherinandp120ctn(i.e.,BEAS-2B
and H358) demonstrate slightly higher SP1 levels (Fig. 4a)
butH157cellswiththelowestE-cadherinandp120ctnlevels
in our panel, demonstrates an SP1 protein level that is
identical to A549 and Rh2 cells both of which with higher
p120ctn levels. Meanwhile we observed a reverse correla-
tion between the mRNA level of CRK-I/II and p120ctn
protein expression in our panel of NSCLC and BEAS-2B
cells. This correlation was notseen betweenp120ctn protein
expressionandmRNAlevelsofMYC,SRC,E2F-1andABL
(data not shown for ABL). In case of SRC, our data shows a
reverse correlation between SRC mRNA levels and p120ctn
expression in a subset of examined cells. In order to conﬁrm
our RT-PCR data, we also measured CRK mRNA levels in
our panel of cell lines by real-time qRT-PCR (Fig. 4c).
Again, the same reverse correlation between total CRK
mRNA level and p120ctn protein expression was observed.
WealsocheckedCRK-I/IIproteinexpressioninourpanelof
NSCLC cell in a western blot (Fig. 5). Again, NSCLC cells
with lower p120ctn expression, (i.e., Rh2 and H157) dem-
onstrate higher levels of CRK-I/II which is in concordance
with our RT-PCR data. The CRK family of adaptor proteins
(i.e.,CRK-I,CRK-II andtheirparalogueCRKL)arecellular
homologues of v-Crk (CT10 avian sarcoma oncogene) that
are involved in transduction of many intracellular signals.
These data suggest that SP1’s role in the transcriptional
regulation of p120ctn is transmitting the suppressive signal
of CRK oncoprotein.
Silencing CRK results in increased p120ctn promoter
activity, mRNA and protein levels
Our earlier results are suggesting a role for proto-oncogene
c-Crk in transcriptional repression of the p120ctn therefore,
we proceeded to examine whether alteration in CRK level
would affect the p120ctn promoter activity and protein
expression levels. Speciﬁcally, we measured p120ctn pro-
moter activity, mRNA and protein levels following siRNA
mediated silencing of CRK in three NSCLC cell lines with
high, intermediate and low CRK levels.
2 p120ctn mRNA
levels measured by real time qRT-PCR is increased by
*2.5-fold in H157 and A549 cells following siRNA
mediated silencing of CRK (Fig. 6). This increase in
p120ctn mRNA transcripts was modest in H358 cells that
have lower levels of CRK at baseline. We also measured
p120ctn promoter activity following siRNA mediated
silencing of CRK in H157, A549 and H358 NSCLC cells.
Again a pattern of increasing p120ctn promoter activity is
observed following silencing CRK which is analogous to
the baseline CRK level in these cells (Fig. 6b). In addition
to p120ctn promoter activity and mRNA level, we also
examined p120ctn protein level following CRK silencing
by siRNA in the above mentioned cell lines by western
blotting (Fig. 7). Relative to non-silencing siRNA, all
examined cell lines show increasing levels of p120ctn
following siRNA mediated silencing of CRK, but again the
relative increase was muted in H358 cells that manifest
lower CRK levels at baseline.
SP1 directly binds to CRK
An interaction between Sp1 and CRK has been proposed
through a peptide array screening [28]. A group of 12 Src
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2 H157, A549 and H358 cells show high, intermediate and low levels
of CRK mRNA at baseline respectively (Fig. 4c).
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123homology (SH3) domains from eight human proteins
including CRK were used to screen for possible interactions
of these proteins in a peptide target array composed of 1536
potential ligands. This screening led to the identiﬁcation of
multiple binary interactions between these proteins and
their targets including the interaction between SP1 and
CRK. Nevertheless, the SP1-CRK interaction has not been
directly investigated to the best of our knowledge. There-
fore, we sought to examine this protein–protein interaction
in a co-immunoprecipitation assay. Indeed, CRK-II
co-immunoprecipitated with SP1 following transient
transfection of CRK-II-myc in 293-T cells and immuno-
precipitation with SP1 antibody (Fig. 8a). In addition,
co-immunoprecipitation of endogenous CRK-II and SP1
was observed in Rh2 NSCLC cells (Fig. 8b). In the reverse
experiment, we detected SP1 in the immunoprecipitate of
A549 and H157 cells isolated with an anti-CRK-II antibody
(Fig. 8c). These successful co-immunoprecipitations, con-
ﬁrm the interaction between SP1 and CRK-II which most
likely takes place through (SH3) domains of CRK-II.
CRK effect on p120ctn expression is mediated through
SP1
To further establish a causal relationship for the CRK and
SP1 interaction in p120ctn transcriptional repression, we
examined the effects of concurrent SP1 and CRK
manipulation on the p120ctn expression. As shown in
Figs. 3, 6 and 7, silencing either SP1 or CRK resulted in
increased levels of p120ctn. Here we examined the effects
of CRK over-expression with or without SP1 silencing to
establish that SP1 is epistatic to CRK in the regulation of
p120ctn expression. Stable expression of CRK-II in A549
NSCLC cells, resulted in lower p120ctn protein level and
promoter activity (Fig. 9). Silencing SP1 in these cells
relieved the CRK-II mediated p120ctn transcriptional
repression and restored p120ctn protein levels. Moreover,
ectopic expression of CRK-I in H358 NSCLC cells also
resulted in a decrease in p120ctn protein levels. We also
observed the relief of CRK-I mediated p120ctn suppres-
sion upon silencing SP1 in these cells. (Supplemental
Fig. 2) Taken together, these results indicate that SP1
functions downstream of CRK vis-a `-vis p120ctn tran-
scriptional regulation.
Discussion
The role of p120ctn in the stability of adherens junctions is
well established. Down-regulation of this protein in several
tumor types including NSCLC [14, 15, 23, 24, 27, 31]
results in heightened tumor invasion and metastasis. Thus,
the identiﬁcation of pathways that participate in the down-
regulation of p120ctn will elucidate the underlying mech-
anisms that drive the metastatic process.
Decreased expression of p120ctn in NSCLC seems to be
the result of transcriptional down-regulation of this gene
[19]. By cloning and analysis of p120ctn promoter, we
have identiﬁed two regions within this promoter that
effectively regulate p120ctn expression. We found that
transcription factors FOXC2 (Fork head related protein)
and SP1 directly bind to segments (?267 and ?282) and
(-9t o?36) of the p120ctn promoter respectively and
mediate transcriptional repression of this gene. Even
though, segment (-9t o?36) of the p120ctn promoter has
an overall activating effect on the transcription of this gene,
deletion of segment (-9t o?36) abolishes the observed
difference in the p120ctn promoter activity between
malignant (A549) and non-malignant (BEAS-2B) respira-
tory cells. Therefore, it seems that both activating and
repressive transcription factors bind to segment (-9t o
?36) and the sum of their effect on the p120ctn tran-
scription is a net activating result. Among the transcription
factors that bind to segment (-9t o?36), SP1 plays a
repressive role manifested as an increase in the p120ctn
promoter activity upon silencing SP1. Other segments of
the p120ctn promoter also seem to have signiﬁcant regu-
latory functions. For example, upon deletion of segment
(-9t o?36) of the p120ctn promoter there is still a
noticeable promoter activity remained (Fig. 2b). This
ﬁnding suggests the role of other cis-acting elements in the
regulation of p120ctn promoter including the NFjB site
immediately 50 to the segment (-9t o?36).
Speciﬁcity protein 1 (SP1) belongs to a family of uni-
versally expressed zinc-ﬁnger DNA binding proteins that
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123are involved in transcriptional regulation of many genes
[26]. SP1 receives several signals from different intracel-
lular pathways and multiple proteins including a number of
other transcription factors that can interact with SP1 and
thereby transduce their respective signal for gene regula-
tion through SP1. Here, we describe the role of CRK (v-crk
sarcoma virus CT10 oncogene homolog) in transcriptional
down-regulation of p120ctn which are mediated through
SP1.
CRK belongs to a family of widely expressed adaptor
proteins that are involved in signal transduction from a
variety of receptors and oncogenes. Examples include:
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123Bcr-Abl; Tel-Abl, Erythropoietin receptor, EGFR, GM-
CSF, Insulin receptor substrate, PDGF and VEGFR [1, 7].
Moreover, as a proto-oncogene, c-Crk expression has been
linked to more aggressive types of tumors including
aggressive forms of NSCLC. Measuring CRK mRNA by
oligonucleotide array in 86 lung adenocarcinoma samples
revealed that CRK mRNA was increased in more
advanced, larger, and poorly differentiated tumors and
correlated with shorter survival of patients [18].
Transcription of the CRK gene results in two different
isoforms (CRK-I and CRK-II). These isoforms translate
into 28 and 42 kDa proteins each one with diverse bio-
logical activities. Following stable transfection of CRK-I
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123and CRK-II isoforms, all cell lines expressing CRK-I
protein exhibited altered morphology, enhanced prolifera-
tion in soft agar, and heightened tumorigenesis in nude
mice [17]. CRK-I/II interact with many downstream targets
including: son of seven less homolog (SOS1); downstream
of CRK (DOCK1) and stress activated protein kinase
(JNK1). Although CRK-I and CRK-II are considered sig-
naling adaptor proteins, they have both cytosolic and
nuclear localizations [10, 16]. The nuclear localization of
CRK suggests that this protein functions as a signal
transmitter from the cytoplasm to the nucleus. Advance-
ment toward understanding CRK biology was made
through a screen for genes involved in cell-death in worms
[22]. Through examination of mutated genes that were
associated with lack of cell migration in C. elegans, a set
of genes were identiﬁed the mammalian counterparts of
which include Crk-II, Dock1, Rac1, and Elmo1. Lack of
cell migration in this model was also observed in Crk-
deﬁcient worms, and this phenotype could be rescued by
introduction of Rac1 or Dock1. As a result, it was sug-
gested that Crk is positioned upstream of Rac1 in this
pathway although direct targets downstream of Crk are still
not well described. Our data shows that CRK negatively
regulates p120ctn transcription in NSCLC cell lines
through interaction with the SP1 transcription factor. It is
worth mentioning that the effect of p120ctn on cell motility
is also mediated through Rac1 [20]. The central role of
CRK in signaling cascades makes it more likely that CRK
affects several downstream targets, including SP1. Here we
describe one of the mechanism through which CRK exerts
its metastasis promoting role by down-regulation of
p120ctn.
In summary, our data provide evidence for the role of
proto-oncogene c-Crk in transcriptional down-regulation of
p120ctn in NSCLC cells which is mediated through tran-
scription factor SP1. Our data provides strong evidence in
support of the interaction between SP1 and CRK-II. Con-
sidering SP1’s wide range of target genes and the central
role of CRK in intracellular signaling, SP1-CRK interac-
tion plays an important and central role in signal
transduction.
These results along with our previous report on the role
of FOXC2 in transcriptional down-regulation of p120ctn in
NSCLC, identiﬁes some of the metastasis promoting
pathways that are abnormally activated in the process of
tumorigenesis in NSCLC. Further attention into these
pathways might provide additional insight to explain the
aggressive behavior of these tumors.
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